Turn Therapeutics Inc. Common Stock (TTRX) — Net Asset Quality Index
Turn Therapeutics Inc. Common Stock (TTRX) has a Net Asset Quality Index of 4.0% as of June 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $16.96 Million minus total liabilities of $16.27 Million yields net assets of $686.89K. A higher index indicates a stronger, lower-leverage balance sheet. Read debt load of Turn Therapeutics Inc. Common Stock for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
Turn Therapeutics Inc. Common Stock Net Asset Quality Index Over Time (2023–2025)
This chart shows how Turn Therapeutics Inc. Common Stock's Net Asset Quality Index has evolved across 3 annual periods from 2023 to 2025. As of June 2026, the index stands at 4.0%, representing net assets of $686.89K against total assets of $16.96 Million USD. For live market cap and overall valuation, see TTRX stock market capitalisation.
Annual Net Asset Quality Index for Turn Therapeutics Inc. Common Stock (2023–2025)
The table below presents the year-by-year Net Asset Quality Index for Turn Therapeutics Inc. Common Stock from 2023 to 2025, covering 3 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. See net assets of Turn Therapeutics Inc. Common Stock for net asset value and shareholders' equity analysis.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 38.5% | $4.69 Million | $12.16 Million | $7.48 Million | ▲ +47.2 pp |
| 2024 | -8.7% | $-177.43K | $2.05 Million | $2.23 Million | ▼ -12.9 pp |
| 2023 | 4.3% | $85.77K | $2.01 Million | $1.93 Million | — |